Xenon Pharmaceuticals (XENE) News Today $38.35 -0.48 (-1.24%) As of 11:46 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock XENE Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Xenon Pharmaceuticals' (XENE) Outperform Rating Reiterated at Royal Bank Of Canada3 hours ago | marketbeat.comADAR1 Capital Management LLC Has $4.28 Million Holdings in Xenon Pharmaceuticals Inc. $XENE5 hours ago | marketbeat.comFirst Light Asset Management LLC Sells 532,676 Shares of Xenon Pharmaceuticals Inc. $XENE5 hours ago | marketbeat.comXenon Pharmaceuticals Inc. $XENE is Vestal Point Capital LP's 9th Largest Position5 hours ago | marketbeat.comBirchview Capital LP Has $705,000 Stake in Xenon Pharmaceuticals Inc. $XENE5 hours ago | marketbeat.comMPM Bioimpact LLC Raises Stock Holdings in Xenon Pharmaceuticals Inc. $XENE5 hours ago | marketbeat.comBaker BROS. Advisors LP Sells 646,271 Shares of Xenon Pharmaceuticals Inc. $XENESeptember 4 at 6:27 AM | marketbeat.comRoyal Bank Of Canada Reiterates Outperform Rating for Xenon Pharmaceuticals (NASDAQ:XENE)September 4 at 2:46 AM | americanbankingnews.comXenon Pharmaceuticals assumed with an Overweight at Wells FargoSeptember 3 at 10:38 AM | msn.comXenon Pharmaceuticals Inc. $XENE Shares Sold by Braidwell LPSeptember 3 at 7:41 AM | marketbeat.comAnalysts Set Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Price Target at $53.20September 1 at 2:31 AM | americanbankingnews.comDriehaus Capital Management LLC Raises Stock Position in Xenon Pharmaceuticals Inc. $XENEAugust 31, 2025 | marketbeat.comSiren L.L.C. Sells 11,008 Shares of Xenon Pharmaceuticals Inc. $XENEAugust 31, 2025 | marketbeat.comXenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Consensus Recommendation of "Buy" by BrokeragesAugust 31, 2025 | marketbeat.comXenon Pharmaceuticals Inc.: Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 30, 2025 | finanznachrichten.deXenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 29, 2025 | financialpost.comFXenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 29, 2025 | globenewswire.comXenon Pharmaceuticals Inc. $XENE Shares Acquired by Affinity Asset Advisors LLCAugust 28, 2025 | marketbeat.comRussell Investments Group Ltd. Has $2.53 Million Stock Position in Xenon Pharmaceuticals Inc. $XENEAugust 27, 2025 | marketbeat.comXenon Pharmaceuticals Inc. $XENE Shares Sold by T. Rowe Price Investment Management Inc.August 26, 2025 | marketbeat.comEntryPoint Capital LLC Makes New $298,000 Investment in Xenon Pharmaceuticals Inc. $XENEAugust 25, 2025 | marketbeat.comDid Higher-Than-Expected Losses Just Shift Xenon Pharmaceuticals' (XENE) Investment Narrative?August 24, 2025 | finance.yahoo.comWellington Management Group LLP Has $127.13 Million Position in Xenon Pharmaceuticals Inc. $XENEAugust 24, 2025 | marketbeat.comXenon Pharmaceuticals Inc. $XENE Shares Sold by Atika Capital Management LLCAugust 23, 2025 | marketbeat.comCandriam S.C.A. Lowers Holdings in Xenon Pharmaceuticals Inc. $XENEAugust 23, 2025 | marketbeat.comXenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)August 23, 2025 | marketbeat.comXenon Pharmaceuticals Inc. $XENE Shares Sold by Algert Global LLCAugust 22, 2025 | marketbeat.comAn Intrinsic Calculation For Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Suggests It's 44% UndervaluedAugust 21, 2025 | finance.yahoo.comXenon Pharmaceuticals Inc. $XENE Shares Acquired by Aberdeen Group plcAugust 21, 2025 | marketbeat.comLord Abbett & CO. LLC Sells 106,990 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)August 19, 2025 | marketbeat.comWhat is Chardan Capital's Forecast for XENE FY2025 Earnings?August 19, 2025 | marketbeat.comXENE FY2025 EPS Estimate Decreased by Cantor FitzgeraldAugust 16, 2025 | marketbeat.comHC Wainwright Analysts Decrease Earnings Estimates for XENEAugust 16, 2025 | marketbeat.comQ3 EPS Estimate for Xenon Pharmaceuticals Lifted by AnalystAugust 16, 2025 | marketbeat.comWilliam Blair Has Negative Estimate for XENE Q3 EarningsAugust 16, 2025 | marketbeat.comWhat is William Blair's Estimate for XENE FY2027 Earnings?August 15, 2025 | marketbeat.comXenon Pharmaceuticals' (XENE) "Buy" Rating Reiterated at Chardan CapitalAugust 14, 2025 | marketbeat.comXenon Pharmaceuticals (NASDAQ:XENE) Shares Gap Up After Analyst UpgradeAugust 13, 2025 | marketbeat.comRoyal Bank Of Canada Has Lowered Expectations for Xenon Pharmaceuticals (NASDAQ:XENE) Stock PriceAugust 13, 2025 | marketbeat.comXenon Pharmaceuticals (NASDAQ:XENE) Given New $43.00 Price Target at WedbushAugust 13, 2025 | marketbeat.comTD Cowen Reaffirms Their Buy Rating on Xenon (XENE)August 13, 2025 | theglobeandmail.comXenon Completes Patient Recruitment for Phase 3 StudyAugust 13, 2025 | theglobeandmail.comXenon Pharmaceuticals (NASDAQ:XENE) Announces Quarterly Earnings ResultsAugust 12, 2025 | marketbeat.comXenon Pharmaceuticals price target lowered to $55 from $57 at RBC CapitalAugust 12, 2025 | msn.comXenon Pharmaceuticals: Pushing Azetukalner Towards Finish Line With Phase 3 2026 Data ReleaseAugust 12, 2025 | seekingalpha.comXenon Pharmaceuticals Reports Q2 2025 Progress and OutlookAugust 12, 2025 | msn.comXenon Pharmaceuticals Inc. (XENE) Q2 2025 Earnings Call TranscriptAugust 11, 2025 | seekingalpha.comXenon Pharmaceuticals: Q2 Earnings SnapshotAugust 11, 2025 | chron.comXenon Pharmaceuticals jumps after massive earnings beatAugust 11, 2025 | investing.comXenon Reports Second Quarter 2025 Financial Results & Business UpdateAugust 11, 2025 | globenewswire.com Get Xenon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for XENE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XENE Media Mentions By Week XENE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XENE News Sentiment▼1.150.69▲Average Medical News Sentiment XENE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XENE Articles This Week▼207▲XENE Articles Average Week Get the Latest News and Ratings for XENE and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Xenon Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Ascendis Pharma A/S News Dr. Reddy's Laboratories News QIAGEN News BridgeBio Pharma News Moderna News Verona Pharma PLC American Depositary Share News Elanco Animal Health News Roivant Sciences News Revolution Medicines News Grifols News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XENE) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
